Status:
COMPLETED
Neurobehavioral Mechanisms of Cocaine Choice
Lead Sponsor:
Joshua A. Lile, Ph.D.
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Cocaine Use Disorder
Eligibility:
All Genders
18-55 years
Phase:
EARLY_PHASE1
Brief Summary
The objective of this protocol is to use a drug-vs-money choice task, reinforcement learning modeling and fMRI to determine the neurobehavioral and neurobiological decision-making "profile" associated...
Eligibility Criteria
Inclusion
- Recent cocaine use, otherwise healthy
Exclusion
- Laboratory results outside of clinically acceptable ranges, history of or current serious physical or psychiatric disease
Key Trial Info
Start Date :
January 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2025
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04296006
Start Date
January 15 2021
End Date
February 1 2025
Last Update
April 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laboratory of Human Behavioral Pharmacology
Lexington, Kentucky, United States, 40536-0086